Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,264,054
+$21,337,100 QoQ
Shares Held
5,825,579
+170.6% QoQ
Ownership
2.85%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 216 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 97%
Shared 1%
None 2%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. ANNX ranks #88 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,264,054 | 5,825,579 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,926,954 | 2,152,880 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,879,098 | 1,768,745 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $7,339,616 | 2,406,432 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,913,557 | 1,630,649 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,624,252 | 841,582 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,756,265 | 1,317,011 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $11,273,917 | 1,904,378 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,921,335 | 596,191 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,036,465 | 562,966 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,293,595 | 284,933 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $579,752 | 245,658 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $307,668 | 87,406 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,294,046 | 336,116 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $278,548 | 53,878 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $429,972 | 69,575 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $292,117 | 77,485 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $895,442 | 328,001 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,869,019 | 162,665 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $591,313 | 31,774 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $501,815 | 22,293 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,707,981 | 133,189 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,347,463 | 93,786 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||